MedDataX Logo

Effects of Isolated Rooms on the Prevalence of Hospital Acquired Pneumonia in a Respiratory ICU

NCT ID: NCT01250691

Last Updated: 2010-12-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

532 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-01-31

Study Completion Date

2010-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will carry out in the ICU. Objectives of the study are to determine the frequency of HAP and the effect of isolated rooms on the frequency of pneumonia in the ICU.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the present study, it was aimed to determine the incidence, causative agents, antimicrobial resistance, and risk factors for lower respiratory tract infections in patients followed in the ICU for the last 4 years. The effect of reconfiguration from a ward-type ICU consisting one large room to an ICU with isolated rooms with two beds on the incidence of HAP was also determined.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia Intensive Care Unit

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

pneumonia ICU isolation room clinical epidemiology infection control

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hospital acquired pneumonia

No interventions assigned to this group

isolated rooms

ward-type ICU

Intervention Type OTHER

frequency of hospital acquired pneumonia in the ICU

ward-type ICU

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ward-type ICU

frequency of hospital acquired pneumonia in the ICU

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

frequency of hospital acquired pneumonia in the ICU

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients,
* admitted to the ICU

Exclusion Criteria

* trauma, surgery or burned patients
* patients under 18
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eskisehir Osmangazi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eskisehir Osmangazi University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Irfan Ucgun, As.Prof.Dr.

Role: STUDY_CHAIR

Eskisehir Osmangazi University, Medical Faculty

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eskisehir Osmangazi University

Eskişehir, Merkez, Turkey (Türkiye)

Site Status

Osmangazi University

Eskişehir, Merkez, Turkey (Türkiye)

Site Status

Eskisehir Osmangazi University

Eskişehir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HAP-OU-isolation

Identifier Type: -

Identifier Source: org_study_id